Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

This Stock Has All the Characteristics of a Benjamin Graham Investment

Page 1 of 2

In his book “The Intelligent Investor,” Benjamin Graham set out some key rules that should be adhered to when analyzing companies in order to establish whether or not they are suitable value investments.

Universal Corp

After recently releasing poor second-quarter results, Universal Corp (NYSE:UVV) sold-off heavily, and it would appear that the company now meets most of Graham’s criteria. I will get into why Universal sold-off and its outlook for growth later, but for now here are the Benjamin Graham investment criteria:

The company must be in a strong financial position; current assets must cover current liabilities at least twice

Long-term debt should not exceed net current assets (working capital)

The company must have been profitable for each year of the past ten

The company must have paid dividends, uninterrupted, for the past 20 years

Over the past ten years, earnings must have grown at least 30%

A P/E ratio of less that 15, taken as an average over the past three years

A P/B value of no more than 1.5 times

Universal adheres to all of these criteria. At the end of the second quarter, the company had a current ratio of 2.5, net current assets were $1.1 billion, and debt was only $523 million. The company has positive earnings for the last 10 years; my data only goes back 10 years, but for this period the company has consistently paid a dividend. Earnings have grown 46% during the last 10-year period, the price-to-book ratio is currently 0.9, and the three-year average P/E is 11.9.

It’s not just the valuation
However, Universal is not just appealing because of its valuation. One thing that really excites me about the company is the fact that, unlike it peers such as Lorillard Inc. (NYSE:LO) and Philip Morris International Inc. (NYSE:PM), which are struggling with falling demand, Universal is actually struggling to keep up with demand for tobacco.

Indeed, Universal’s CEO mentioned on the company’s second-quarter earnings call that he was surprised by how strong tobacco demand had been this year. That said, the company’s second-quarter revenue did drop, but this was mostly due to a lack of supply, as this excerpt from the conference call shows:

In the United States where crop sizes have been negatively affected by recent high levels of rainfall. Burley crop levels are down from earlier projections in some origins, exacerbating the under-supply conditions expected for that type of tobacco this year. In addition, global demand is strong, and we are seeing volatile green- tobacco prices in Brazil that have disrupted markets and pressured margins there.

Management expects good results during the second half of the year, as crop plantings are already under way and good yields are expected.

Meanwhile peers are struggling
On the other hand, while Universal struggles to keep up with demand, Philip Morris is watching its volumes decline. During the second quarter, Philip Morris’ cigarette shipment volume fell 3.9%, which took the total decline of cigarettes shipped during the first half of 2013 to 5.1%. The company was hit hard by the increase in excise taxes on cigarettes within the Philippines. Excluding the Philippines, the total number of cigarettes shipped for the second quarter fell 2.6%.

However, what really concerns me about Philip Morris’ second quarter and indeed, first-half results, is the 5.9% decline in the number of Marlboro-branded cigarettes sold during the second quarter.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!